Valuation: Stereotaxis, Inc.

Market Cap 129M 113M 105M 96.33M 181M 12.38B 184M 1.25B 487M 6.08B 482M 472M 21.04B P/E 2026 *
-6.45x
P/E 2027 * -8.6x
Enterprise Value 129M 113M 105M 96.33M 181M 12.38B 184M 1.25B 487M 6.08B 482M 472M 21.04B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 2.41x
Free-Float
84.7%
Yield 2026 *
-
Yield 2027 * -
1 day-8.51%
1 week-16.77%
Current month-25.00%
1 month-20.37%
3 months-33.16%
6 months-51.69%
Current year-43.91%
1 week 1.28
Extreme 1.28
1.63
1 month 1.28
Extreme 1.28
1.94
Current year 1.28
Extreme 1.28
2.86
1 year 1.28
Extreme 1.28
3.59
3 years 1.28
Extreme 1.28
3.59
5 years 1.28
Extreme 1.28
9.94
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 02/02/2017
Director of Finance/CFO 57 30/09/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 31/01/2005
Chairman - 02/02/2017
Director/Board Member 71 28/09/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
Change 5-day change 1-year change 3-year change Capi.($)
-8.51%-16.77%-42.67%-14.00% 129M
-0.71%+6.72%+18.80%-0.46% 211B
-0.52%-6.05%-6.80%-25.11% 135B
+1.65%-2.29%-31.94%+1.99% 119B
+1.54%+0.50%-58.31%-15.57% 65.77B
-1.42%-3.62%+3.29%-9.87% 47.58B
+3.03%-0.17%-26.91%-33.60% 44.44B
-0.84%+5.41%+15.30%+8.84% 39.14B
-2.02%+1.54%+23.68%+30.76% 36.79B
-1.41%+3.99%+77.58%+2.50% 29.37B
Average -0.92%-1.25%-2.80%-5.45% 72.82B
Weighted average by Cap. -0.01%+0.36%-2.59%-6.42%

Financials

2026 *2027 *
Net sales 39.4M 34.61M 32.18M 29.53M 55.49M 3.79B 56.34M 382M 149M 1.87B 148M 145M 6.45B 53.28M 46.79M 43.52M 39.93M 75.03M 5.13B 76.18M 517M 202M 2.52B 200M 196M 8.72B
Net income -19.4M -17.04M -15.85M -14.54M -27.32M -1.87B -27.74M -188M -73.51M -918M -72.83M -71.26M -3.18B -13.62M -11.97M -11.13M -10.21M -19.19M -1.31B -19.48M -132M -51.63M -645M -51.15M -50.05M -2.23B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
24/07/26 US$1.290 -8.51% 1,304,506
23/07/26 US$1.410 -5.37% 1,520,057
22/07/26 US$1.490 +1.36% 569,430
21/07/26 US$1.470 -2.00% 1,544,194
20/07/26 US$1.500 -3.23% 1,810,328
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.290USD
Average target price
4.125USD
Spread / Average Target
+219.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock